Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Thromb Haemost. 2009 Dec 11;8(3):548–555. doi: 10.1111/j.1538-7836.2009.03723.x

Fig. 6.

Fig. 6

PolyP does not interfere with heparin-catalyzed inhibition of thrombin by antithrombin. (A) Residual thrombin activity (A405/min) was measured after incubating 25 nM thrombin with 50 nM antithrombin and 0–1000 U/ml heparin in the absence (○) or presence (●) of 37.5 µM polyP75. The zero point refers to antithrombin inhibition of thrombin without heparin. (B) Residual thrombin activity (A405/min) was measured after incubating 25 nM thrombin with 50 nM antithrombin and 0–375 µM PolyP75 in the absence (○) or presence (●) of 0.01 U/ml heparin. The zero points refer to antithrombin inhibition of thrombin (± heparin) in the absence of polyP75. Data represent mean ± S.D. (n = 3).